Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1979 Dec;42(6):664–670. doi: 10.1136/hrt.42.6.664

Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.

J Mehta, M Iacona, C J Pepine, C R Conti
PMCID: PMC482219  PMID: 534583

Abstract

The haemodynamic effects of oral prazosin and hydralazine were evaluated in patients with refractory heart failure and compared with those of intravenous nitroprusside in the same patients. Both oral agents were well tolerated and appeared to have beneficial haemodynamic effects. Prazosin and hydralazine produced similar increases in cardiac output associated with a similar decrease in systemic vascular resistance. Prazosin and hydralazine produced similar increases in cardiac output associated with a similar decrease in systemic vascular resistance. Prazosin resulted in a more significant decline in left ventricular filling pressure and pulmonary vascular resistance than did hydralazine. Haemodynamic alterations induced by prazosin were similar to those induced by nitroprusside, which suggests a relatively balanced reduction of preload and afterload. With hydralazine, the increase in cardiac output without change in left ventricular filling pressure or pulmonary vascular resistance suggests minimal effect on preload but significant reduction in afterload.

Full text

PDF
664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awan N. A., Miller R. R., DeMaria A. N., Maxwell K. S., Neumann A., Mason D. T. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Circulation. 1977 Sep;56(3):346–354. doi: 10.1161/01.cir.56.3.346. [DOI] [PubMed] [Google Scholar]
  2. Bolen J. L., Alderman E. L. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation. 1976 May;53(5):879–883. doi: 10.1161/01.cir.53.5.879. [DOI] [PubMed] [Google Scholar]
  3. Chatterjee K., Drew D., Parmley W. W., Klausner S. C., Polansky J., Zacherle B. Combination vasodilator therapy for severe chronic congestive heart failure. Ann Intern Med. 1976 Oct;85(4):467–470. doi: 10.7326/0003-4819-85-4-467. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee K., Parmley W. W., Ganz W., Forrester J., Walinsky P., Crexells C., Swan H. J. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation. 1973 Dec;48(6):1183–1193. doi: 10.1161/01.cir.48.6.1183. [DOI] [PubMed] [Google Scholar]
  5. Chatterjee K., Parmley W. W., Massie B., Greenberg B., Werner J., Klausner S., Norman A. Oral hydralazine therapy for chronic refractory heart failure. Circulation. 1976 Dec;54(6):879–883. doi: 10.1161/01.cir.54.6.879. [DOI] [PubMed] [Google Scholar]
  6. Chatterjee K., Parmley W. W., Swan H. J., Berman G., Forrester J., Marcus H. S. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation. 1973 Oct;48(4):684–690. doi: 10.1161/01.cir.48.4.684. [DOI] [PubMed] [Google Scholar]
  7. Chatterjee K., Parmley W. W. The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis. 1977 Jan-Feb;19(4):301–325. doi: 10.1016/0033-0620(77)90006-8. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance. Circulation. 1973 Jul;48(1):5–8. doi: 10.1161/01.cir.48.1.5. [DOI] [PubMed] [Google Scholar]
  9. Franciosa J. A., Limas C. J., Guiha N. H., Rodriguera E., Cohn J. N. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet. 1972 Mar 25;1(7752):650–654. doi: 10.1016/s0140-6736(72)90460-6. [DOI] [PubMed] [Google Scholar]
  10. Franciosa J. A., Mikulic E., Cohn J. N., Jose E., Fabie A. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation. 1974 Nov;50(5):1020–1024. doi: 10.1161/01.cir.50.5.1020. [DOI] [PubMed] [Google Scholar]
  11. Franciosa J. A., Pierpont G., Cohn J. N. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med. 1977 Apr;86(4):388–393. doi: 10.7326/0003-4819-86-4-388. [DOI] [PubMed] [Google Scholar]
  12. Ganz W., Swan H. J. Measurement of blood flow by thermodilution. Am J Cardiol. 1972 Feb;29(2):241–246. doi: 10.1016/0002-9149(72)90635-2. [DOI] [PubMed] [Google Scholar]
  13. Guiha N. H., Cohn J. N., Mikulic E., Franciosa J. A., Limas C. J. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974 Sep 19;291(12):587–592. doi: 10.1056/NEJM197409192911201. [DOI] [PubMed] [Google Scholar]
  14. Khatri I., Uemura N., Notargiacomo A., Freis E. D. Direct and reflex cardiostimulating effects of hydralazine. Am J Cardiol. 1977 Jul;40(1):39–42. doi: 10.1016/0002-9149(77)90097-2. [DOI] [PubMed] [Google Scholar]
  15. Koch-Weser J., Graham R. M., Pettinger W. A. Drug therapy. Prazosin. N Engl J Med. 1979 Feb 1;300(5):232–236. doi: 10.1056/NEJM197902013000505. [DOI] [PubMed] [Google Scholar]
  16. Majid P. A., Sharma B., Taylor S. H. Phentolamine for vasodilator treatment of severe heart-failure. Lancet. 1971 Oct 2;2(7727):719–724. doi: 10.1016/s0140-6736(71)92098-8. [DOI] [PubMed] [Google Scholar]
  17. Mantle J. A., Russell R. O., Jr, Moraski R. E., Rackley C. E. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. Am J Cardiol. 1976 Feb;37(2):263–268. doi: 10.1016/0002-9149(76)90322-2. [DOI] [PubMed] [Google Scholar]
  18. Mehta J., Iacona M., Feldman R. L., Pepine C. J., Conti C. R. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. Am J Cardiol. 1978 May 1;41(5):925–930. doi: 10.1016/0002-9149(78)90735-x. [DOI] [PubMed] [Google Scholar]
  19. Mehta J., Pepine C. J., Conti C. R. Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure. Br Heart J. 1978 Aug;40(8):845–850. doi: 10.1136/hrt.40.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miller R. R., Awan N. A., Maxwell K. S., Mason D. T. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. N Engl J Med. 1977 Aug 11;297(6):303–307. doi: 10.1056/NEJM197708112970604. [DOI] [PubMed] [Google Scholar]
  21. Miller R. R., Vismara L. A., Williams D. O., Amsterdam E. A., Mason D. T. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ Res. 1976 Jul;39(1):127–133. doi: 10.1161/01.res.39.1.127. [DOI] [PubMed] [Google Scholar]
  22. Pepine C. J., Nichols W. W., Conti C. R. Aortic input impedance in heart failure. Circulation. 1978 Sep;58(3 Pt 1):460–465. doi: 10.1161/01.cir.58.3.460. [DOI] [PubMed] [Google Scholar]
  23. Pierpont G. L., Cohn J. N., Franciosa J. A. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest. 1978 Jan;73(1):8–13. doi: 10.1378/chest.73.1.8. [DOI] [PubMed] [Google Scholar]
  24. SONNENBLICK E. H., DOWNING S. E. Afterload as a primary determinat of ventricular performance. Am J Physiol. 1963 Apr;204:604–610. doi: 10.1152/ajplegacy.1963.204.4.604. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES